Aktueller Stellenwert der Device-Therapie

• Verfasst von: Kuschyk, Jürgen [VerfasserIn]
• Verfasst von: Rudic, Boris [VerfasserIn]
• Verfasst von: Borggrefe, Martin [VerfasserIn]
• Verfasst von: Akın, Ibrahim [VerfasserIn]
• Titel: Aktueller Stellenwert der Device-Therapie
• Verf.angabe: J. Kuschyk, B. Rudic, M. Borggrefe, I. Akin
• E-Jahr: 2017
• Jahr: April 2017
• Umfang: 11 S.
• Fussnoten: Gesehen am 31.10.2018
• Titel Quelle: Enthalten in: Herz
• Ort Quelle: München : Urban & Vogel, 1997
• Jahr Quelle: 2017
• Band/Heft Quelle: 42(2017), 2, Seite 151-161
• ISSN Quelle: 1615-6692
• DOI: doi:10.1007/s00059-017-4548-3
• Datenträger: Online-Ressource
• Sprache: ger
• Sach-SW: Autonome Modulation
• Sach-SW: Autonomic modulation
• Sach-SW: Cardiac contractility modulation
• Sach-SW: Chronic heart failure
• Sach-SW: Chronische Herzinsuffizienz
• Sach-SW: Defibrillatoren
• Sach-SW: Defibrillators
• Sach-SW: Kardiale Kontraktilitätsmodulation
• Sach-SW: Plötzlicher Herztod
• Sach-SW: Sudden cardiac death
• K10plus-PPN: 158246913X

Abstract

Sudden cardiac death and chronic heart failure are among the main contributors to persisting high mortality rates in Germany. In addition to removal of causal factors and guideline-conform pharmacological therapy, therapy with cardiac implantable electronic devices (CIED) is of undisputed importance. Subcutaneous defibrillators have the advantage that they do not have intracardiac electrodes but still have the same efficacy and safety. For patients with a wide QRS complex and reduced ejection fraction, cardiac resynchronization has led to a reduction of morbidity and mortality. For patients with a normal QRS complex, cardiac contractility modulation had been shown to improve the quality of life, exercise capacity and left ventricular function. As a procedure for autonomic modulation in patients with reduced cardiac strength, the data for baroreceptor stimulation are the most convincing.